What to Expect After a PFO Closure Procedure

Most people who undergo PFO closure go home the same day or the next morning, and the physical recovery is relatively quick compared with open-heart procedures. Because the device is placed through a catheter threaded from a vein in your groin, there is no chest incision and no general anesthesia in many cases. But “quick” does not mean “nothing to think about.” The weeks and months that follow involve a specific medication schedule, a temporary risk of heart-rhythm disturbances, follow-up imaging to confirm the closure is holding, and some activity limitations that taper off over time. Understanding the timeline helps separate normal post-procedure sensations from things that genuinely need a phone call to your cardiologist.

The First Day and Going Home

PFO closure is a catheter-based procedure. The interventional cardiologist inserts the device through a vein at your groin, guides it up to the heart, and deploys a small double-disc occluder across the PFO. The puncture site in your groin is typically sealed with a suture-based closure device at the end of the case.¹ You will lie flat for a few hours afterward so the groin site can stabilize, and nurses will check your pulse, blood pressure, and the access site repeatedly during that window. Mild groin soreness and a small bruise are normal and usually fade within a week or two.

Many centers now discharge patients the same day once the monitoring period is completed without problems. The safety outcomes that the medical team watches for in those first hours include access-site bleeding, device embolization (the device slipping out of position), stroke symptoms, and early arrhythmia.¹ If everything looks stable, you head home with a set of discharge instructions and prescriptions.

Medications You Will Take Afterward

Almost everyone leaves the hospital on blood-thinning medication. The standard approach is antiplatelet therapy, most commonly a single antiplatelet drug, prescribed for at least six months. In a large cohort study, about two-thirds of patients received single antiplatelet therapy at discharge, while the remaining patients were placed on dual antiplatelet therapy or a combination involving anticoagulants depending on their individual risk factors.² If you have a known clotting disorder, your team may add a low-molecular-weight heparin injection for the first month alongside an antiplatelet agent.²

The purpose of these medications is to prevent clots from forming on the device while your heart tissue slowly grows over it. That biological process, called endothelialization, takes months. An angioscopic study of one patient’s device at 12 months confirmed that the occluder was covered with new tissue by that point.³ Once the device is fully incorporated into your heart wall, the risk of device-related clotting drops substantially, and most patients eventually stop antiplatelet therapy on their cardiologist’s recommendation.

Activity Restrictions and Returning to Exercise

For the first week or so, you will be told to avoid heavy lifting and strenuous exercise to protect the groin access site. Most people can return to light activity, desk work, and normal daily routines within a few days. Driving is usually fine once you are off any sedation and feel comfortable with the movements involved, which for many people is within two to three days.

If you are on dual antiplatelet therapy, contact sports and activities with a meaningful risk of trauma are typically off limits until you switch down to a single antiplatelet agent. International guidelines recommend disqualification from competition and contact-sport training during the dual therapy period. A long-term follow-up study of athletes who had PFO or ASD closure found that once patients switched to single antiplatelet therapy, they could safely return to all sports, including those with collision risk.⁴ That said, the researchers noted that bleeding events on single therapy were unrelated to sports participation but that sport-specific judgment is still warranted, particularly if your activity involves hard impacts. When possible, shortening the duration of antiplatelet therapy helps minimize bleeding risk for active people.⁴

The Arrhythmia Window

One of the most commonly discussed side effects of PFO closure is new-onset atrial fibrillation. This catches people off guard because you went in for a structural fix and came out with a rhythm issue you did not have before. The good news is that post-closure atrial fibrillation is overwhelmingly a temporary phenomenon. A meta-analysis of the randomized trials found that about 3% of patients developed early-onset atrial fibrillation within the first 45 days, compared with a much lower rate after that window.⁵ The peak seems to cluster around the two-week mark after the procedure.⁶

Why does it happen? The device sits across the atrial septum and physically stretches and irritates the surrounding tissue, which can trigger erratic electrical signals. As the heart tissue heals and incorporates the device, this irritation subsides. In the meta-analysis, three-quarters of patients who developed atrial fibrillation after closure had no recurrence: their episodes resolved on their own or with a brief course of medication or cardioversion.⁵ If you feel palpitations, a racing or irregular heartbeat, or lightheadedness in the first few weeks, let your medical team know. They may prescribe a short-term rhythm-control medication; flecainide has shown promise for this specific situation.⁶ Post-closure atrial fibrillation is generally considered benign and the episodes usually stop within about 45 days.

Follow-Up Imaging and Checking for Residual Shunt

Your cardiologist will schedule a follow-up echocardiogram, usually around six months, to check whether the closure is holding. This typically involves a bubble study: a small amount of agitated saline is injected into your vein while the ultrasound watches your heart. If no bubbles cross from the right side to the left, the closure is complete. If bubbles do cross, you have what is called a residual shunt.

Residual shunts are more common than you might expect, and the timing of the test matters. One study found that even when no shunt was detected immediately after device placement, about 37% of those patients showed some degree of residual shunt at six months when tested with a Valsalva maneuver (bearing down to increase pressure in the chest). About a fifth of those were moderate or large.⁷ If a residual shunt is found at six months, many centers repeat the imaging at 12 months, because the device may still be in the process of being covered by tissue.⁸

A small residual shunt does not necessarily mean the procedure failed, and many small shunts are clinically insignificant. In rare cases where a persistent, hemodynamically meaningful shunt is identified and linked to recurrent symptoms, advanced imaging techniques can pinpoint the leak’s location and guide a second catheter-based closure.⁹

How Well Does Closure Prevent Future Strokes?

If you had your PFO closed because of a cryptogenic stroke, the question you care about most is whether it will happen again. The data here is reassuring. A meta-analysis of randomized trials found that the risk of recurrent ischemic stroke was roughly 40% lower in patients who had device closure compared with those on medication alone.¹⁰ One of the landmark trials, with long-term follow-up data, showed the stroke rate in the closure group was roughly half that of the medical-therapy group over years of observation.¹¹

A pooled analysis of six randomized trials added a useful detail about timing: the benefit of closure over medication alone tends to become apparent after about the first year and persists without fading. The analysis estimated that about 11 patients need to undergo PFO closure to prevent one stroke compared with medical therapy alone.¹² That number-needed-to-treat might sound high, but for a one-time procedure in a relatively young stroke patient, the accumulated protection over decades of life is substantial.

Nickel Sensitivity and Device Syndrome

Most PFO closure devices are made from a nickel-titanium alloy called Nitinol. If you have a nickel allergy, this matters more than you might assume. A randomized trial found that about 29% of patients tested positive for nickel hypersensitivity before their procedure. Among those patients, the rate of what researchers call “device syndrome,” a cluster of symptoms including new or worsened migraines, palpitations, and chest discomfort, was dramatically higher: roughly 71% compared with about 21% in patients without nickel allergy. Nickel hypersensitivity was associated with more than a tenfold increase in the odds of developing device syndrome.¹³

If you know you are allergic to nickel (a common finding in people who react to costume jewelry or belt buckles), bring it up with your cardiologist before the procedure. Alternative devices exist. A long-term study of a platinum-coated occluder designed for nickel-sensitive patients found no serious post-procedure events and only one case of mild, self-resolving skin irritation.¹⁴ This is a solvable problem, but only if it is identified beforehand.

Dental Work and Antibiotic Prophylaxis

You may not immediately connect heart surgery with your dentist, but there is a direct link. During invasive dental or oral procedures, bacteria can enter your bloodstream. While the PFO device is still exposed (before full tissue coverage), those bacteria could theoretically settle on it and cause an infection called endocarditis. The 2018 American College of Cardiology/AHA guidelines recommend that patients with a PFO closure device take preventive antibiotics before invasive dental procedures for six months after implantation, or longer if a residual shunt remains adjacent to the device.¹⁵ Endocarditis on a PFO occluder is rare, but case reports confirm it can occur even years after implantation.¹⁶ Make sure your dentist knows about your device, and carry a card or note from your cardiologist specifying what prophylaxis you need.

Changes in Migraines

Many people with a PFO also experience migraines, particularly migraines with aura. If that describes you, there is a reasonable chance that closure will improve your headache pattern, although it is not a guaranteed cure. A meta-analysis found that PFO closure significantly reduced the number of monthly migraine days and monthly migraine attacks compared with medical treatment alone.¹⁷ A separate meta-analysis confirmed a similar direction: monthly migraine days dropped and monthly attacks decreased in the closure group relative to drug therapy.¹⁸

The benefits are most pronounced in people who have aura with their migraines and especially in those who have aura with more than half of their attacks. In a pooled analysis, complete migraine cessation occurred in about 9% of the device group versus under 1% of the medical therapy group, and migraineurs with frequent aura saw reductions across all measured endpoints.¹⁹ Keep in mind that PFO closure is not currently approved specifically for migraine treatment; any migraine improvement is considered a secondary benefit when the procedure is done for stroke prevention. But it is a welcome one for the people who experience it.

Exercise Capacity and Breathing

Some patients who had a PFO discovered through unexplained low oxygen levels or exertional breathlessness notice a real change after closure. A study of patients with exercise-induced oxygen desaturation found that, three months after closure, the average drop in blood oxygen during exertion improved dramatically, and functional capacity improved meaningfully as well.²⁰ Quality-of-life scores after PFO closure in a small cohort met or exceeded the general population averages for most patients, though people with other significant health problems like severe osteoporosis scored lower.²¹

Not everyone has this kind of dramatic improvement, of course. If your PFO was discovered because of a stroke and you never had noticeable desaturation or exercise limitations, you may not feel any different physically after closure. The device is doing its work silently in the background, preventing potential future events rather than resolving symptoms you can feel day-to-day.

The Psychological Side of Recovery

This is an underappreciated aspect of PFO closure recovery. A qualitative study that interviewed patients about their experience identified several recurring themes: fear and anxiety about having had a stroke, apprehension about the device inside their heart, and uncertainty about what activities were safe. Some patients reported lingering fatigue, which they found hard to separate from neurological fatigue after the stroke itself. Others described a subjective decline in physical activity compared to before their stroke, even when their cardiologist gave them the green light to be active.²²

If you find yourself feeling anxious about the device, worried about exercising, or simply not bouncing back emotionally the way you expected, that is a normal and well-documented part of this recovery. Having a stroke at a young age, which describes most PFO closure patients, is psychologically jarring in a way that a structural heart fix cannot fully address. Talking to your medical team about these feelings, and potentially connecting with a therapist who has experience with cardiac patients, is a reasonable step that many people find helpful.

Scuba Diving After Closure

PFO closure is sometimes performed specifically because a diver suffered decompression sickness linked to a right-to-left shunt. If that is your situation, or if you are a recreational diver wondering about getting back in the water, the evidence is cautiously positive. A study of divers who returned to diving after PFO closure found that the practice appeared fairly safe, though the authors recommended conservative diving profiles, especially if any residual shunt remained.²³ Conservative in the diving world means shorter bottom times, slower ascents, longer safety stops, and avoiding repetitive or deep dives that push decompression limits. Even with a closed PFO, prudent dive planning is the standard recommendation.

Rare Complications Worth Knowing About

The overall safety profile of PFO closure is strong. Serious complications are uncommon, but they are not zero, and it helps to know what is in the realm of possibility. Device embolization, where the occluder migrates from its intended position, is the one that sounds scariest. A randomized trial comparing three different PFO devices over a median of seven years found no cases of device erosion or embolization requiring cardiac surgery in one device group, though embolization did occur in a small number of patients using a different design.²⁴ Another trial comparing three devices reported embolizations exclusively in one specific device type and thrombus formation on the device in a small percentage of cases, concentrated in another design.²⁵

Very late mechanical dysfunction is exceptionally rare but has been reported. One case involved a patient who had multiple strokes three years after closure due to a structural problem with the device and clot formation on it.²⁶ Reports like these are published precisely because they are unusual; they serve as reminders that follow-up matters, not as reasons to panic. If you develop new neurological symptoms at any point after closure, seek medical attention promptly regardless of how long ago the procedure was.

Which Device You Received Can Matter

Not all PFO occluders perform identically. A head-to-head randomized trial following patients for five years compared the Amplatzer, Helex, and CardioSEAL-STARflex devices. Complete closure rates after a single implantation were highest with the Amplatzer device at about 99%, compared with roughly 97% for CardioSEAL-STARflex and about 92% for Helex. The combined rate of stroke, transient ischemic attack, and cerebral death over five years was lowest in the Amplatzer group at about 1.4%.²⁵ Device-related thrombus was found overwhelmingly with the CardioSEAL-STARflex design. The Amplatzer device (and its current successors) has become the most widely used occluder partly because of results like these.

If you are not sure which device you received, ask your cardiologist. It is worth having a record of the device name and size in your personal health file, especially since this information matters for future imaging, dental prophylaxis decisions, and any interactions with MRI machines. Modern PFO occluders are MRI-conditional, meaning they are safe in MRI scanners under specific conditions, but knowing your exact device helps the radiology team confirm compatibility.